View Our Latest Research Report on TPST Tempest Therapeutics Trading Down 6.3 % NASDAQ TPST opened at $7.34 on Wednesday. Tempest Therapeutics, Inc. has a 1-year low of $5.35 and a 1-year high of ...

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with ...

Story April 21 - Tempest Therapeutics: Days after starting to look for partners, the company has moved to lay off 21 of its 26 full-time employees to stretch its limited cash reserves. The cuts ...

At close: May 2 at 4:00:00 PM EDT ...

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate ...

A surge in business energy demand is reshaping the global energy landscape ? and pushing energy providers to rethink how they support growth and deliver value. According to new EY research, two-thirds ...

Renoworks Software Inc. ("Renoworks" or the "Company), an industry leader in visualization and lead generation technology for the home remodel and new construction sector, announces its first quarter ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on ...